Home » Drug Information » FDA-Approved Drugs » 1997
Medical Areas: Endocrinology | Psychiatry/Psychology
View By: Year Company Therapeutic Areas Drug Names
Drug Information
The following information is obtained from various newswires, published
medical journal articles, and medical conference presentations.
Company: Teva Pharmaceutical
Approval Status: Approved May 1997
Treatment Area: depression
Trazadone 150mg tablets have been approved to manufacture and
market as a treatment for depression. Teva previously received
approval for 50mg and 100mg dosage strengths. Trazadone is the
generic equivalent of Bristol Meyers Squibb’s Desyrel 7.
